Retina: A sight concern

Monday 22 October 2007 19:00 EDT
Comments

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

Having lost the sight in one eye when I was 17, due to a detached retina, I am concerned about the sight in my other eye. Early this year, I was diagnosed with age-related macular degeneration (AMD) in that eye and referred to hospital, where I had scans but no treatment. Finally, I was referred to a specialist who did another scan. He suggested an injection into the eye, but said there was no guarantee it would work, and I could lose my sight altogether.

Dr Fred Kavalier answers your health question:

Age-related macular degeneration gradually destroys vision in the central part of the retina (the macula), responsible for sharp vision. AMD comes in two forms wet and dry. Some treatments are available for wet AMD, but there is currently no effective treatment for dry AMD. People who are developing wet AMD sometimes notice that straight lines appear wavy. One of the first symptoms of dry AMD is slightly blurred vision. The newest, and probably best treatment for wet AMD is a drug that is injected into the eye to stop the development of new fragile blood vessels, the cause of visual loss. The new treatments are not widely available on the NHS, but the RNIB is campaigning to change this. To find out more, see www.rnib.org.uk.

Please mail your questions for Dr Fred to health@independent.co.uk. He regrets that he is unable to respond personally to questions.

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in